Connection

Carlo Lombardi to Proteasome Inhibitors

Back to Details
This is a "connection" page, showing publications Carlo Lombardi has written about Proteasome Inhibitors.
Carlo Lombardi
Connection Strength
0.175
Proteasome Inhibitors
  1. Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects. Eur J Pharmacol. 2018 Nov 05; 838:85-90.
    View in: PubMed
    Score: 0.175
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.